Lacrimal drainage system stenosis associated with Trastuzumab emtansine (Kadcyla®, T-DM1) administration: a case report

BACKGROUND: Trastuzumab emtansine (Kadcyla®, T-DM1) is an antibody-drug conjugate used to treat HER2 (human epidermal growth factor receptor 2) overexpressing metastatic breast cancer. In this report, we present the first case of lacrimal drainage system stenosis identified after T-DM1 administratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chung Young, Kim, Namju, Choung, Ho-Kyung, In Khwarg, Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683558/
https://www.ncbi.nlm.nih.gov/pubmed/31387552
http://dx.doi.org/10.1186/s12885-019-5986-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683558/
https://www.ncbi.nlm.nih.gov/pubmed/31387552
http://dx.doi.org/10.1186/s12885-019-5986-5

Ejemplares similares